J&J shares fall but $8 billion jury award likely to be slashed

(Reuters) - Johnson & Johnson shares were off more than 2% on Wednesday, a day after a U.S. jury said it must pay $8 billion (6.6 billion pounds) in punitive damages to a plaintiff in a case involving its anti-psychotic drug Risperdal, a penalty the company and others are confident will not stand.The jury in a Philadelphia court awarded the $8 billion to a man who previously won $680,000 over his claims that it failed to warn that young men using Risperdal could grow breasts.J&J called the sum..